83 Tumor immune microenvironment characterization from pre- and post-dose tumors collected from a phase 1/2 study of NDI-101150, a hematopoietic progenitor kinase 1 (HPK1) inhibitor

Daigle, S. R., Elliott, G., Boiko, S., Sommerhalder, D., Noel, M. S., Sharma, S., Balaraman, R., Gutierrez, M., Demel, K., Moy, R. H., Ciccone, D., Zhang, X., Scheuber, A., & Kumar, P. (2024). 83 Tumor immune microenvironment characterization from pre- and post-dose tumors collected from a phase 1/2 study of NDI-101150, a hematopoietic progenitor kinase 1 (HPK1) inhibitor. Regular and Young Investigator Award Abstracts, A91–A91. https://doi.org/10.1136/jitc-2024-sitc2024.0083
Authors:
Scott R. Daigle
GiNell Elliott
Scott Boiko
David Sommerhalder
Marcus Smith Noel
Sunil Sharma
Rama Balaraman
Martin Gutierrez
Kurt Demel
Ryan H. Moy
David N. Ciccone
Xinyan Zhang
Anita Scheuber
Pavan Kumar
Affiliated Authors:
Ryan H. Moy
Columbia Affiliation:
Subjects:
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
Cancer Stem Cells and Tumor Metastasis (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2024-sitc2024.0083
DOI:
10.1136/jitc-2024-sitc2024.0083
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: